Veeva Systems Income from Continuous Operations 2012-2025 | VEEV
Veeva Systems annual/quarterly income from continuous operations history and growth rate from 2012 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Veeva Systems income from continuous operations for the quarter ending April 30, 2025 was $0.228B, a 41.15% increase year-over-year.
- Veeva Systems income from continuous operations for the twelve months ending April 30, 2025 was $0.781B, a 40.45% increase year-over-year.
- Veeva Systems annual income from continuous operations for 2025 was $0.714B, a 35.84% increase from 2024.
- Veeva Systems annual income from continuous operations for 2024 was $0.526B, a 7.79% increase from 2023.
- Veeva Systems annual income from continuous operations for 2023 was $0.488B, a 14.11% increase from 2022.
| Veeva Systems Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025 | $714 |
| 2024 | $526 |
| 2023 | $488 |
| 2022 | $427 |
| 2021 | $380 |
| 2020 | $301 |
| 2019 | $230 |
| 2018 | $151 |
| 2017 | $78 |
| 2016 | $54 |
| 2015 | $40 |
| 2014 | $24 |
| 2013 | $19 |
| 2012 | $4 |
| 2011 | $4 |
| Veeva Systems Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-04-30 | $228 |
| 2025-01-31 | $196 |
| 2024-10-31 | $186 |
| 2024-07-31 | $171 |
| 2024-04-30 | $162 |
| 2024-01-31 | $147 |
| 2023-10-31 | $135 |
| 2023-07-31 | $112 |
| 2023-04-30 | $132 |
| 2023-01-31 | $189 |
| 2022-10-31 | $108 |
| 2022-07-31 | $91 |
| 2022-04-30 | $100 |
| 2022-01-31 | $97 |
| 2021-10-31 | $106 |
| 2021-07-31 | $109 |
| 2021-04-30 | $116 |
| 2021-01-31 | $103 |
| 2020-10-31 | $97 |
| 2020-07-31 | $94 |
| 2020-04-30 | $87 |
| 2020-01-31 | $66 |
| 2019-10-31 | $82 |
| 2019-07-31 | $79 |
| 2019-04-30 | $73 |
| 2019-01-31 | $71 |
| 2018-10-31 | $64 |
| 2018-07-31 | $50 |
| 2018-04-30 | $44 |
| 2018-01-31 | $41 |
| 2017-10-31 | $35 |
| 2017-07-31 | $39 |
| 2017-04-30 | $37 |
| 2017-01-31 | $30 |
| 2016-10-31 | $22 |
| 2016-07-31 | $13 |
| 2016-04-30 | $13 |
| 2016-01-31 | $18 |
| 2015-10-31 | $10 |
| 2015-07-31 | $13 |
| 2015-04-30 | $13 |
| 2015-01-31 | $13 |
| 2014-10-31 | $10 |
| 2014-07-31 | $10 |
| 2014-04-30 | $7 |
| 2014-01-31 | $6 |
| 2013-10-31 | $7 |
| 2013-07-31 | $6 |
| 2013-04-30 | $5 |
| 2013-01-31 | |
| 2012-10-31 | $6 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $46.313B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.516B | 0.00 |
| Doximity (DOCS) | United States | $11.474B | 53.12 |
| Hims & Hers Health (HIMS) | United States | $11.060B | 114.91 |
| IRhythm Technologies (IRTC) | United States | $4.939B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.905B | 61.02 |
| Hinge Health (HNGE) | United States | $3.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.815B | 10.12 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.444B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.405B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 65.08 |
| Omnicell (OMCL) | United States | $1.376B | 24.28 |
| Evolent Health (EVH) | United States | $1.310B | 111.60 |
| Claritev (CTEV) | United States | $0.716B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.452B | 0.00 |
| TruBridge (TBRG) | United States | $0.349B | 773.33 |
| Outset Medical (OM) | United States | $0.338B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.109B | 0.00 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |